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Abstract 
 
Women with benign breast tumors could experience decreased in quality of life (QoL) due to 
pain and fear over the disease. This study aimed to investigate the QoL outcome in benign breast 
tumor patients who receive alternative treatment with jamu. A total of 26 female patients who came 
to Rumah Riset Jamu (RRJ) "Hortus Medicus" Tawangmangu in the period of September-December 
2013 with complaints of breast tumor  and met the inclusion criteria were included in this study. They 
were given Jamu formula for breast tumor and drank its water infusion twice daily for 16 weeks. Short 
Form-36 (SF-36) scores was measure at baseline, middle and the end of study. SF-36 is a tool to assess 
the QoL that has been widely used in health research. The mean scores of SF-36 is elevated in middle 
and the end of study compare to baseline. There were significant differences between the mean scores 
before and after treatment (paired t test, p<0,05). The results showed that Jamu had the potential to 
improve quality of life in patients with benign breast tumor. 
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INTRODUCTION 
 
Benign breast tumors occupy the highest 
prevalence compared with other types of tumors in 
women (Guray and Sahin, 2016). Although has the 
lower mortality compared to breast cancer, attention 
regarding management of this tumor is needed 
because it can affect the quality of life (QoL) and 
productivity of the sufferers (Goehring and Morabia, 
1997). Pain in the region of the tumor, depressed and 
anxious feeling about the disease are the factors 
causing a decrease in the QoL in patients with 
benign breast tumors (Deane and Degner, 1998). 
Andrykowski, et al. study (1996) showed that 
patients with breast cancer and benign breast had no 
different level of psychological stress. 
Rumah Riset Jamu (RRJ) “Hortus Medicus” 
is a type A Jamu Clinic, under the responsibility of 
Medicinal Plant and Traditional Medicine Research 
and Development Centre, Ministry of Health. As 
part of Indonesian Government "Jamu 
Saintification" program implementation, RRJ 
becomes  a place for clinical trials of Jamu. RRJ has 
dual function, research and services. Jamu clinical 
trials conducted in order to find  evidence base 
regarding efficacy and safety of native Indonesia 
herbal medicines (Kemenkes RI, 2010). 
In the year of 2013 RRJ performed clinical 
trials related to Jamu as an alternative therapy to the 
benign breast tumors. This study measured QoL as 
one of outcome parameters Assessment of QoL 
using the form -36 short which is already widely 
used in health research in the world and proved its 
validity (Ware and Sherboune, 1992; Lindley, et al., 
1998). This study aimed to investigate the QoL 
outcome in benign breast tumor patients who receive 
alternative treatment with jamu. 
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METHODS 
 
A total of 26 female patients who came to 
Rumah Riset Jamu (RRJ) "Hortus Medicus" 
Tawangmangu in the period of September-December 
2013 with complaints of breast tumor and met the 
inclusion criteria were included in this study. 
Inclusion criteria: women who suffer from 
fibroadeno mammae (FAM) type of benign breast 
tumor (diagnose confirmed with history, physical 
examination, breast ultrasound, and anatomic 
pathology examination of fine needle aspiration 
biopsy (FNAB), the patient's age between 17-50 
years, the patient was willing to follow the schedule 
of follow-up study and willing to signed informed 
consent. Exclusion criteria: patients who are 
hypersensitive to any of the components of the Jamu 
Formula, patients taking drugs or other herbs that 
has the same function, pregnant and lactation women 
(based on recognition), patients with complications 
of severe disease, such as heart failure NYHA III 
and IV, severe gastritis, acute  myocardial infarction. 
The subjects of this study consumed Jamu 
Formula as an alternative therapy for them that 
consist of temu mangga rhizomes (Curcuma manga), 
white turmeric rhizome (Kaemferia rotunda), green 
tea leaves (Camellia sinensis), mistletoe (Scurulla 
sp) and bidara upas rhizomes (Merremia mamosa) 
with certain dose. Jamu Formula boiled in 4 cups of 
water in the morning for about 15 minutes until the 
water remaining 2 cups to drink one glass in the 
morning and one glass in the evening. Jamu was 
taken daily for 16 weeks. Assessment of QoL using 
a Short From 36 (SF-36)  performed at baseline, 
middle and the end of study. 
SF-36 containing 36 grains of questions. 
Answer choices ranged from 2 to 6 possibility. 
Value ranges from 0 to 100. The value of 100 is the 
best QoL and the value 0 as the worst. SF-36 contain 
8 dimensional measurement, physical function (PF), 
role limitation due to physical health (RLPH), role 
limitations due to emotional problems (RLEP), 
energy/fatigue (E), emotional well being (EWB), 
social function (SF), pain (P) and general health 
(GH). There are two steps in scoring SF-36 (RAND, 
2016).  
This  study  has  received  ethical  approval 
from the Ethics Committee of Health Research, 
Ministry of Health with number LB. 
02.01/5.2/KE/456/2013. 
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Table I. Step 1: Recoding Items 
Item numbers 
Change original 
response category * 
To recoded 
value of: 
1, 2, 20, 22, 34, 36 1 → 100 
 2 → 75 
 3 → 50 
 4 → 25 
 5 → 0 
3, 4, 5, 6, 7, 8, 9, 10, 11, 12  1 → 0 
 2 → 50 
 3 → 100 
13, 14, 15, 16, 17, 18, 19 1 → 0 
 2 → 100 
21, 23, 26, 27, 30  1 → 100 
 2 → 80 
 3 → 60 
 4 → 40 
 5 → 20 
 6 → 0 
24, 25, 28, 29, 31 1 → 0 
 2 → 20 
 3 → 40 
 4 → 60 
 5 → 80 
 6 → 100 
32,33,35 1 → 0 
 2 → 25 
 3 → 50 
 4 → 75 
 5 → 100 
*Precoded response choices as printed in the questionnaire. 
 
 
 
Table 2. Step 2: Averaging Items to Form Scales 
Scale Number of items 
After recoding per Table 1,  
average the following items 
Physical function (PF)  10 3 4 5 6 7 8 9 10 11 12 
Role limitations due to physical health (RLPH) 4 13 14 15 16 
Role limitations due to emotional problems(RLEP) 3 17 18 19 
Energy/fatigue(E) 4 23 27 29 31 
Emotional well-being(EWB) 5 24 25 26 28 30 
Social functioning(SF) 2 20 32 
Pain (P) 2 21 22 
General health(GH) 5 1 33 34 35 36 
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RESULT AND DISCUSSION 
 
In this study, total score and scores for each 
dimension of the SF-36 was measured. 
Mean scores of QoL experienced an increase 
at the end of the study, from 64.05 becoming 79.34. 
Analysis using Paired t test obtained p=0.000 
(p<0.05), which means that there are significant 
differences in QoL scores before and after 
intervention with  jamu (Table 3). 
These eight SF-36 dimensions mean score 
increased after the intervention for 56 days and is 
increasing at the end of the intervention (day 112) 
except the dimension of energy decreased slightly on 
day 112 compared to day 56 (Fig. 1). Factors beyond 
the disease could be the cause of the decline, such 
as: the activity in which many SF-36 when charging 
is done. 
The statistical test showed significantly 
different mean scores for each dimension of the SF-
36 in D-56 and D-112 in comparison with the D-0 
(Table IV). SF-36 is a QoL assessment tool that is 
widely used in research related to tumors and breast 
cancer. These eight SF-36 dimensions represent two 
aspects: the physical and mental aspects. 
FAM is a type of benign breast tumor most 
often found. It is usually a disease of early 
reproductive life; the peak incidence is between the 
ages of 15 and 35 years (Guray and Sahin, 2016). 
The current management of patients with clinically 
or radiologically suspected fibroadenoma varies. 
Some physicians prefer excision for tissue diagnosis, 
but conservative management will likely replace 
surgical treatment in the near future (Guray and 
Sahin, 2016). One of alternative management in 
patient with FAM is by drinking herbal remedy like 
Jamu.  
 
 
 
Table 3. The Average of SF-36 Scores 
 N Mean P 
SF-36 (D-0) 26 64.05  
SF-36 (D-56) 26 75.88 0.000* 
SF-36 (D-112) 26 79.34 0.000* 
    *paired t test with p = 0.000 (< 0.05) 
  
 
 
 
 
 
Figure 1. Increasing of SF 36  Mean. A total of 26 female patients in Rumah Riset Jamu (RRJ) "Hortus Medicus" 
Tawangmangu in the period of September-December 2013 who diagnosed.  
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Table IV. mean of SF-36 Dimension 
Dimension Mean P 
PF D-0 82.11 + 15.24  
PF D-56 85.77 + 12.12 0.039* 
PF D-112 89.61 + 10.67 0.001* 
RLPH D-0 50.96+ 42.71  
RLPH D-56 78.35 + 33.48 0.001** 
RLPH D-112 81.73 + 28.77 0.001** 
RLEP D-0 53.85 + 47.21  
RLEP D-56 80.45 + 35.35 0.009** 
RLEP D-112 89.745 + 24.53 0.007** 
E D-0 65.96 + 18.22  
E D-56 76.92 + 11.32 0.02* 
E D-112 74.12 + 19.10 0.016* 
EWB D-0 67.31 + 18.29  
EWB D-56 75.23 + 14.36 0.014* 
EWB D-112 76 +14.4 0.001* 
SF D-0 55.29 + 24.59  
SF D-56 68.46 +18.82 0.001* 
SF D-112 73.27 + 16.74 0.000* 
P D-0 54.81 + 22.49  
P D-56 66.54+ 18.71 0.001* 
P D-112 75.29+ 16.74 0.000* 
GH D-0 49.42 + 16.3  
GH D-56 60.38 + 16.30 0.000* 
GH D-112 63.27 + 17.60 0.000* 
        * paired t test comparing each measurement with H-0  
        ** Wilcoxon test comparing each measurement with H-0 
 
 
Jamu formula for tumor consist of herbs that 
has been used by Indonesian since centuries. Anti-
tumor activity of each herbs in this Jamu Formula 
have been scientifically proven. Malek, et al. from 
the Institute of Biological Sciences, University of 
Malaysia  find 7 active compounds in Temu Mangga 
rhizomes, namely: (E) -labda-8 (17), 12-dien-15,16-
dial (1), (E) -15.16-bisnor-labda-8 (17), 11-dien-13-
one (2), zerumin A (3), β-sitosterol, curcumin, and 
bis-demethoxycurcumin 8 demethoxycurcumin. In 
vitro study of this active compound has revealed its 
cytotoxic effect in breast tumor cells. Green tea 
leaves, mistletoe and white turmeric contain 
compounds that function as potent antioxidants, have 
the ability in cleaning free radicals and inhibit the 
growth of tumor (Lotulung, et al., 2008; Shrubsole, 
et al., 2009; Ali, et al., 2013; Nasution and Roza, 
2013). Empirically Bidara Upas rhizomes  used to 
treat tumors, sore throat, typhoid fever and cough 
(Widyaningrum and Rahmad, 2011). Yan, et al. in 
2010 managed to isolat 8 phenolic compounds, 
including new compounds salicylic acid derivative 
SA 2-O-β-D- (3 ', 6'-dicaffeoyl) –glucopyranoside. 
 
 
 
 
CONCLUSION 
 
The results showed that Jamu had the 
potential to improve QoL in patients with benign 
breast tumor. 
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